Clinical Trials
13 trialsNCT06866964 2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT05683808 2026-01-30
VTE-POG
University of Vermont Medical Center
Phase 2 Recruiting
NCT04243122 2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2 Completed
NCT03297359 2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2 Terminated
NCT04106700 2021-02-15
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
Instituto de Investigacion Sanitaria La Fe
Phase 2 Terminated
NCT02366871 2020-03-31
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Phase 2 Completed
NCT03195010 2019-10-21
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Fred Hutchinson Cancer Center
Phase 2 Terminated
NCT00952380 2019-04-16
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
Pfizer
Phase 2 Completed
NCT02048865 2018-11-20
AVERT
Ottawa Hospital Research Institute
Phase 2 Completed
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT01524653 2018-07-10
DISOLVE
University of Vermont
Phase 2 Completed
NCT00981903 2017-07-06
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
University of Southern California
Phase 2 Terminated
NCT00790452 2011-12-08
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
M.D. Anderson Cancer Center
Phase 2 Terminated